Dogwood Therapeutics, Inc. Common Stock
DWTXDogwood Therapeutics, Inc. (DWTX) is a biotechnology company focused on developing innovative therapies targeting the central nervous system and ophthalmic conditions. The company leverages its expertise in drug discovery and development to create novel treatments for neurological disorders, with an emphasis on improving patient outcomes through precision medicine approaches.
$2.85 -0.30 (-9.52%)
Company News
Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising Chemotherapy Adoption | DelveInsight
The chemotherapy-induced peripheral neuropathy (CIPN) treatment market is expected to grow significantly between 2025-2034, driven by rising cancer incidence, lack of approved therapies, and emerging novel drug treatments.
